Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans

Abstract

A major concern in common disease epigenomics is distinguishing causal from consequential epigenetic variation. One means of addressing this issue is to identify the temporal origins of epigenetic variants via longitudinal analyses. However, prospective birth-cohort studies are expensive and time consuming. Here, we report DNA methylomics of archived Guthrie cards for the retrospective longitudinal analyses of in-utero-derived DNA methylation variation. We first validate two methodologies for generating comprehensive DNA methylomes from Guthrie cards. Then, using an integrated epigenomic/ genomic analysis of Guthrie cards and follow-up samplings, we identify interindividual DNA methylation variation that is present both at birth and 3 yr later. These findings suggest that disease-relevant epigenetic variation could be detected at birth, i.e., before overt clinical disease. Guthrie card methylomics offers a potentially powerful and cost-effective strategy for studying the dynamics of interindividual epigenomic variation in a range of common human diseases.

Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips

“…1), suggesting their promise for future clinical application. However, Robinson et al 21,22 found that genetic variation, including single nucleotide contribute to predominantly HCV-related HCC in the US. A total of 130,512 CpG sites across the entire genome significantly differ in methylation levels between HCC tumor and adjacent non-tumor tissues after Bonferroni correction for multiple comparisons.…”

Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies

“…38 Therefore, if possible, profiling both blood and buccals will not be redundant but rather provide complementary information. However, in the case of an EWAS of a non-blood disease/phenotype, if a choice has to be made between the two surrogate tissues, then buccal may be more informative.…”

Development of DNA Confirmatory and High-Risk Diagnostic Testing for Newborns Using Targeted Next-Generation DNA Sequencing

“…31,32 Using our methods, we see similarly high-quality TNGS performance of DNA isolated from DBS as compared with the standard 10 ml of whole blood and saliva (Supplementary Figure S1 online). With a control sample set, our protocols yielded ~450 ng doublestranded DNA (dsDNA) from one-half of a single saturated spot from the DBS card, representing 25 µl blood (as measured by the dsDNA-specific Qubit assay; Supplementary Table S2 online).…”